Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors (GARNET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02715284
Recruitment Status : Recruiting
First Posted : March 22, 2016
Last Update Posted : June 11, 2020
Sponsor:
Information provided by (Responsible Party):
Tesaro, Inc.